Avid Bioservices to Participate at Upcoming Investor Conferences

On September 2, 2021 Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, reported that the company will participate in two upcoming investor conferences (Press release, Avid Bioservices, SEP 2, 2021, View Source [SID1234587169]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the company’s participation are as follows:

Morgan Stanley 19th Annual Global Healthcare Conference
Details: Avid management will participate in a fireside chat and 1-on-1 meetings
Conference Dates: September 9-10 and 13-15, 2021
Fireside Chat Timing: 2:45 – 3:15 p.m. Eastern on Thursday, September 9, 2021
Format: Virtual conference; webcast available
HC Wainwright 23rd Annual Global Investment Conference
Details: Avid management will deliver a corporate presentation and participate in 1-on-1 meetings
Conference Dates: September 13-15, 2021
Presentation Timing: Available online at 7:00 a.m. Eastern on Monday, September 13, 2021
Format: Virtual conference
To listen to the live webcast of the Morgan Stanley fireside chat, or access the archived webcast, please visit: View Source

Moderna to Present at Upcoming Investor Conferences in September 2021

On September 2, 2021 Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, reported its participation in the following upcoming virtual investor conferences (Press release, Moderna Therapeutics, SEP 2, 2021, View Source [SID1234587204]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo 2021 Virtual Healthcare Conference on Friday, September 10, 2021 at 10:00 a.m. ET
Morgan Stanley 19th Annual Global Healthcare Conference on Friday, September 10, 2021 at 11:45 a.m. ET
A live webcast of each presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. A replay of each webcast will be archived on Moderna’s website for 30 days following the presentation.

MediciNova to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

On September 2, 2021 MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), reported that MediciNova will participate in the virtual Morgan Stanley 19th Annual Global Healthcare Conference which will be held from September 9 – 15, 2021 (Press release, MediciNova, SEP 2, 2021, View Source [SID1234587240]). Yuichi Iwaki, MD, PhD, President and Chief Executive Officer, and Geoffrey O’Brien, JD/MBA, Vice President and Executive Officer, will be available for one-on-one meetings at this conference and investors may request a one-on-one meeting through Morgan Stanley.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference

On September 2, 2021 Bio-Techne Corporation (NASDAQ: TECH) reported that Chuck Kummeth, President and Chief Executive Officer, will present at the 2021 Virtual Wells Fargo Healthcare Conference on Thursday, September 9, 2021 at 2:00 p.m. EDT (Press release, Bio-Techne, SEP 2, 2021, View Source [SID1234587153]). A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne’s Investor Relations website at View Source

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Neurocrine Biosciences to Present at Upcoming Healthcare Conferences

On September 2, 2021 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) reported that members of the management team will participate at the following virtual investor conferences (Press release, Neurocrine Biosciences, SEP 2, 2021, View Source [SID1234587170]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Kevin Gorman, Chief Executive Officer, will present at the Morgan Stanley 19th Annual Healthcare Conference at 10:15 a.m. ET on Monday, Sept. 13, 2021.
Matt Abernethy, Chief Financial Officer, and Eiry Roberts, Chief Medical Officer, will present at the Baird 2021 Global Healthcare Conference at 10:50 a.m. ET on Wednesday, Sept. 15, 2021.
The live presentation will be webcast and may be accessed on the Company’s website under Investors at www.neurocrine.com. A replay of the presentation will be available on the website approximately one hour after the conclusion of the events and will be archived for approximately one month.